SGS. G. Gorbunov

S. G. Gorbunov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


S. G. Gorbunov has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Coinfection caused by hepatitis C virus and human pegivirus in an 11-year-old teenager with aplastic anemia

    by O. N. Kandoba, V. A. Greshnyakova, S. G. Gorbunov, N. D. Odinaeva

    Chronic hepatitis C is an urgent problem for Russian healthcare, including in pediatric practice. Currently, this infection can be successfully treated with the use of direct antiviral drugs. However, in some cases, due to the common ways of infection, especially with hemotransfusions, there is an infection caused by the hepatitis C virus and human pegivirus, the role of which is still not completely clear. A clinical observation from our own practice demonstrates the effectiveness of glecaprevir/pibrentasvir in an 11-year-old coinfected patient who received multiple blood transfusions against hepatitis C virus while maintaining pegivirus replication, which may have negatively affected the course of concomitant hematological disease.

  • Clinical and laboratory characteristics of chronic hepatitis C in children with different levels of aminotransferases

    by S. G. Gorbunov, O. N. Kandoba, N. D. Odinaeva

    Aminotransferases reflect the volume and degree of liver damage with the development of inflammation in chronic hepatitis C, correlate with fibrosis, therefore their determination in such patients is of both scientific and practical importance. The aim of the study is determination of the clinical course, dynamics of laboratory and instrumental parameters in children with HCV who received direct antiviral therapy, depending on the initial level of aminotransferases in blood serum. Materials and methods . 36 patients aged 3—16 years were under observation, randomized depending on the level of aminotransferases in the blood serum. All children underwent a regulated clinical, laboratory and instrumental examination before starting treatment with the direct antiviral drug glecaprevir/pibrentasvir, 12 weeks and 6 months after the start of the course of therapy. Results . Patients with high levels of aminotransferases were more likely to become infected with HCV perinatal compared with children with normal levels of these enzymes in the blood serum. The age and clinical symptoms in both groups did not differ. Aminotransferases were initially elevated in 27.8% of children with chronic hepatitis C, while their maximum level did not exceed 4 norms. The appointment of a course of direct antiviral therapy with glecaprevir / pibrentasvir contributes to a fairly rapid and stable normalization of aminotransferase levels in all patients in both groups, regardless of their initial amount. HCV genotype 1b prevailed in both children with high levels of aminotransferases and those with normal levels, and the viral load was low in the group with normal levels of aminotransferases. Faster normalization of liver size according to ultrasound data in patients with normal aminotransferase levels under the influence of direct antiviral therapy indicates a direct correlation between the level of aminotransferases and the degree of liver damage in chronic hepatitis C. However, more pronounced fibrosis in 1 child (up to grade F3 on the METAVIR scale) in this group indicates the need for close attention even to those children whose aminotransferase levels remain normal, which does not exclude the course of their fibrotic process in the liver. Conclusion . Thus, it can be assumed that the baseline level of aminotransferases in children with HCV is important for assessing the degree of liver damage and allows predicting the effectiveness of direct antiviral therapy.

  • Open Access

    Features of the course of COVID-19 in children with hypochromic anemia

    by S. G. Gorbunov, A. V. Bitsueva, N. D. Odinaeva, A. A. Cheburkin

    According to the literature, patients with hypochromic anemia are considered a "risk group" for an unfavorable course of COVID-19. It has been established that hypochromic iron deficiency anemia has a negative impact on virtually all aspects of the immune system, which play a key role in protecting the body from the SARS-CoV-2 virus. The development of COVID-19 leads to changes in iron homeostasis—the so-called inflammatory anemia—which negatively impacts the course of this infection.Objective: to determine the features of the clinical course, laboratory and instrumental examination data, and to analyze the effectiveness of COVID-19 treatment in children with hypochromic anemia.Materials and methods: in 2022–2024, 60 children with COVID-19 suffering from hypochromic anemia (observation group) and 60 children with this infection without anemia (comparison group) were examined in accordance with regulatory documents.Results: The severity of the condition in observation group was determined by the degree of damage to the respiratory tract, fever and intoxication, as well as diarrhea. From laboratory data, patients with COVID-19 and hypochromic anemia are characterized by a decrease in the level of red blood cells and hemoglobin, and a tendency to hypercoagulation. The severity of the inflammatory process in them was more reflected by CRP than ferritin. In order to achieve a favorable outcome, patients in this group needed longer treatment for all types of therapy they receive in children without anemia.Conclusion: COVID-19 in children with hypochromic anemia is more severe than in patients suffering from this infection without anemia.

  • Open Access

    Experience of using a direct-acting antiviral drug in children with chronic hepatitis C in the Moscow region

    by S. G. Gorbunov, O. N. Kandoba, N. D. Odinaeva

    Russia ranks among the first countries both in Europe and around the world in terms of the number of children infected with the hepatitis C virus, which determines the medical and social importance of this problem for domestic healthcare. The aim of the study was to evaluate the clinical and laboratory features of the course and effectiveness of direct antiviral therapy of HCV in children and adolescents living in the Moscow region. Materials and methods. 28 children (13 boys and 15 girls) aged 3—16 years with HCV were under observation. The genotype of the pathogen was determined for all children before the start of antiviral therapy, and before and after completing an 8-week course of treatment with the direct antiviral drug glecaprevir+pibrentasvir, the viral load was determined by PCR, IgM and IgG antibodies to HCV by ELISA, clinical and biochemical blood tests, coagulogram, ultrasound of the abdominal organs and fibroelastography were performed. the liver. Results. Chronic hepatitis C (HCV) is detected mainly in school-age children (in 67.9%), in 60.7% of patients it is combined with other various pathologies. Infection occurs in 89.3% of cases during perinatal contact with a mother with HCV. The clinical picture is characterized by low symptoms, asthenia prevails (weakness — 35.8%, decreased appetite — 32.1%, headache — 7.2%, dizziness — 3.6%, drowsiness — 3.6%) and impaired motor function of the gastrointestinal tract (17.9%). Cytolysis syndrome is slightly pronounced, it is noted in 39.3—42.9% of children. Genotypes 1b (32.1%), 3a (25%) and 1a (17.9%) predominate. According to ultrasound data, hepatomegaly is observed in 28.6% of children, fibrosis grade F1 on the METAVIR scale is formed in 39.3% of patients. Antiviral therapy provides a stable virological response in 100% of cases and contributes to the normalization of biochemical parameters, as well as regression of fibrosis in all children treated with glecaprevir+pibrentasvir for 8 weeks. Conclusion. Currently, the most effective method for the further spread of hepatitis C is the early detection and treatment of children and adolescents suffering from this infection using direct antiviral agents.


  • Open Access

    Diagnosis and treatment of children with acute surgical diseases of the abdominal organs and acute intestinal infections

    by S. A. Korovin, K. Imaraliev, С. Б. Оробинский, A. V. Dzyadchik, S. G. Gorbunov, Yu. Yu. Sokolov, Ю. Ю. Соколов

    Introduction. The clinical manifestations of acute surgical diseases of the abdominal organs in children may be similar to acute intestinal infections. To date, there remains a need to optimize the therapeutic and diagnostic algorithm in children due to the emergence of “new” and expanding the range of rare nosologies of “acute abdomen” with atypical clinical manifestations of diseases for certain age groups of children.Aim. To optimize the treatment and diagnostic algorithm for children with acute surgical diseases of the abdominal organs and acute infectious diseases.Materials and methods. The study included 437 children with acute surgical diseases of the abdominal cavity and acute infectious diseases. All patients underwent examinations at the preoperative stage in accordance with the clinical protocol for the diagnosis and treatment of acute surgical diseases in children. The volume of surgical intervention was determined during laparoscopy. The average age of the patients was 10.23 ± 3.3 years. The prehospital period is 15.9 ± 8.5 hours. The preoperative period was 14.6 ± 7.6 hours. The coincidence of diagnoses at admission/clinical was 413/331 (80%).Results and discussion. Three variants of clinical and instrumental manifestations of acute surgical diseases of the abdominal cavity in combination with acute intestinal infections in children have been identified. Reliable differences between individual indicators of clinical and anamnestic, instrumental and intraoperative data in groups of patients with acute surgical and infectious diseases have been proved.Conclusion. The atypical course of acute abdominal symptoms in children from the younger age group is due to a predominance of systemic inflammatory responses over local symptoms in 30% of cases. It is justified to intensify diagnostic measures, such as expanding the indications for laparoscopy, in children from younger age groups.

  • Study of the quality of life of children and adolescents who have suffered acute respiratory infections, acute gastroenteritis, and Epstein–Barr virus infection

    by S.G. Gorbunov, I.A. Nikulina

    As some of the most common diseases in pediatric practice, acute respiratory, intestinal, and herpesvirus infections have a negative impact on patients' quality of life even after their main symptoms have been relieved. There has been virtually no research into objective indicators of quality of life for these diseases. Objective. To assess the quality of life of children who have suffered from acute respiratory infections (ARI), acute gastroenteritis, and Epstein–Barr virus infection (EBVI) during the period of clinical manifestation of the disease and during early convalescence. Patients and methods. In an observational, single-center, prospective, selective, uncontrolled study, we examined the quality of life indicators of 50 children aged 5–17 years who had suffered from ARI (n = 24), acute gastroenteritis (n = 11), and EBVI (n = 15). The HUI2 and HUI3 questionnaires, adapted and validated for Russian clinical practice, were used to assess quality of life. The questionnaires were administered in person on the 1st and 7th days of hospitalization, as well as 3 months after discharge from the hospital via telephone interview. The quality of life indicator after 3 months served as a control value for quality of life. Results. In patients with ARI, acute gastroenteritis, and EBVI, the HUI2 and HUI3 health indices in the acute period were significantly lower than in the control group: 0.88 ± 0.03 vs. 0.97 ± 0.01 (р < 0.05) and 0.84 ± 0.04 vs. 0.97 ± 0.01 (р < 0.01), respectively; 0.76 ± 0.04 vs. 0.97 ± 0.01 (р < 0.001) and 0.58 ± 0.10 vs. 0.97 ± 0.01 (р < 0.001); 0.82 ± 0.04 vs. 0.97 ± 0.01 (р < 0.001) and 0.74 ± 0.07 vs. 0.97 ± 0.01 (р < 0.01). Emotional disorders, incidence, severity, and ability to control pain were also noted. The most pronounced disturbances in quality of life were observed in patients who had suffered from acute gastroenteritis. Conclusion. Considering the data obtained in the study, practicing physicians should strive not only to relieve the symptoms of the infections in question, but also to normalize the quality of life of convalescents. Key words: quality of life, health indices, acute respiratory infections, acute gastroenteritis, Epstein–Barr virus infection, children

  • Open Access

    Features of the course of COVID-19 in children with the spread of the Omicron variant

    by T. A. Ruzhentsova, A. A. Garbuzov, A. V. Bitsueva, O. V. Rubleva, S. G. Gorbunov, N. A. Meshkova, R. V. Popova, E. N. Morozova

    The aim of the study was to assess the symptoms and identify risk factors for prolonged and complicated COVID-19 during the spread of the Omicron variant in children aged 1 month to 18 years. Materials and methods. The study included 110 children with confirmed COVID-19 of mild or moderate severity at the time of the first examination. The average age of the patients was 6.86±5.09 years. The clinical symptoms, duration of each of the identified symptoms, and complications were evaluated. Acomparative analysis of possible risk factors for prolonged course and development of pneumonia was carried out. Results. The most common cases in children with COVID-19 were an increase in body temperature (in93%), runny nose (in65%), cough (in59%), hyperemia of the posterior pharyngeal wall (in95%) and tonsils (in93%), an increase in regional lymph nodes - in 43%. Among children with the duration of COVID-19 for 10 days or more, astatistically significant late request for medical help (onaverage, by 8.26±5.46 days, compared with 3.00 ± 1.32 days with the duration of the disease up to 10 days). Pneumonia is most often registered among preschool children. The average age in the group of children diagnosed with pneumonia is significantly less than in children who did not have signs of pneumonia of this complication (4.66 ±4.78 and 7.17±4.81, respectively). Conclusions: With the spread of the Omicron variant COVID-19 in children, infection with the SARS-CoV-2 coronavirus is accompanied by symptoms of acute respiratory infection with an increase in body temperature, sore throat, hyperemia of the posterior wall of the pharynx and tonsils. Often there is an increase in regional lymph nodes, runny nose, cough, vomiting, less often - diarrhea. The prolonged course is facilitated by the late onset of adequate therapy. During the study, pneumonia was detected in 25% of children.

  • Open Access

    COVID-19 and obesity in children: clinical and diagnostic parallels

    by S. G. Gorbunov, A. V. Bitsueva, A. A. Cheburkin, N. D. Odinayeva

    Purpose: determination of the clinical course; laboratory and instrumental examination data; and analysis of the effectiveness of COVID-19 treatment in obese children.Materials and methods. 50 children with COVID-19 who were obese and 50 children with this infection who had a normal body weight were under observation. All patients underwent general clinical physical examination; laboratory studies (PCR analysis of smears from the mouth and nasopharynx for SARS-CoV-2 RNA; clinical and biochemical blood tests; general urine analysis; coagulogram; blood test for proteins of the acute phase of inflammation); instrumental studies (pulsoximetry; CT of organs chest). In addition; weight; height and body mass index were determined for all children. Statistical processing of the obtained results was carried out using the nonparametric Mann-Whitney test and the parametric Student t-test for independent samples.Summary. 34% of obese patients had a history of other various background diseases. In this group; 76% of children had contact with acute respiratory infections in the family or organized groups. In both groups; all children had fever and intoxication; sore throat and rhinitis – in 24-36%; vomiting and diarrhea – in 10-12%. Significantly more often in obese patients; symptoms of respiratory tract damage such as cough (98% vs. 62%) and shortness of breath (36% vs. 2%) were observed. The duration of fever; intoxication; cough and shortness of breath in the group of obese patients was significantly higher compared to children in the comparison group. Obese patients had significantly higher CRP levels during hospitalization (18;6 vs. 8;4 mg/l); whereas by the time of discharge the differences had already been leveled (5;5 vs. 1;9 mg/l). In the observation group; the ferritin content was significantly higher relative to the comparison group both upon admission to the hospital (195;1 vs. 62;5 ng/ml) and after the end of the course of treatment (166;7 vs. 54;6 ng/ml). Lung damage according to CT studies in obese patients with COVID-19 was significantly more common than in the comparison group – 59;0±7;0% vs. 8;0±3;8%. They also developed grade I of respiratory failure more often; because the minimum SpO2 was lower than normal and lower relative to children with normal body weight (94;8±2;0% vs. 98;3±0;8%). Obese children required significantly longer treatment of COVID-19 relative to the comparison group for all types of therapy they received. As a result; these patients spent significantly more bed days in the hospital – 9;3±3;6 vs. 6;2±2;0.Conclusion. COVID-19 in obese children is more severe than in patients with normal body weight; which required long-term complex treatment in a hospital.


  • Epidemiology of rotavirus infection: the evolution of the pathogen and the success of vaccination

    by S. G. Gorbunov, A. A. Cheburkin

    The review presents data on the spread of various rotavirus genotypes and its variability in the world and in Russia, which occur both due to natural causes and under the influence of vaccination against rotavirus infection, as well as on the transformation of clinical and epidemiological features of the course of this disease in children as a result of the pathogen mutations.

  • Open Access

    Epidemiological features of intestinal infection associated with Klebsiella pneumonia in infants and young children

    by N. V. Gonchar, A. K. Kopersak, A. M. Moskalyuk, S. G. Grigor’EV, S. G. Gorbunov

    Эпидемиологические особенности кишечной инфекции, ассоциированной с Klebsiella pneumonia , у детей грудного и раннего возраста